The Duke University School of Medicine, commonly known as Duke Med, is the medical school of Duke University. It is located in the Collegiate Gothic-style West Campus of Duke University in Durham, North Carolina.

During the past decade, Duke University School of Medicine conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 13 clinical trials were completed, i.e. on average, 40.6% percent of trials that started reached the finish line to date. In the past 5 years, 17 clinical trials started and 4 clinical trials were completed. i.e. 23.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Duke University School of Medicine" #1 sponsor was "Duke University" with 8 trials, followed by "Milton S. Hershey Medical Center" with 4 trials sponsored, "Janssen Research & Development, LLC" with 3 trials sponsored, "Harmony Biosciences, LLC" with 2 trials sponsored and "Amarantus BioScience Holdings, Inc." with 2 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Duke University School of Medicine" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 8 trials as a collaborator, "Duke University" with 5 trials as a collaborator, "National Institutes of Health (NIH)" with 4 trials as a collaborator, "National Institute on Drug Abuse (NIDA)" with 2 trials as a collaborator and "American Lung Association Asthma Clinical Research Centers" with 1 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 39 trials.

According to Clinical.Site data, the most researched conditions in "Duke University School of Medicine" are "Asthma" (7 trials), "Cigarette Smoking" (3 trials), "Chronic Kidney Disease" (2 trials), "Idiopathic Hypersomnia" (2 trials) and "Acute Pain" (1 trials). Many other conditions were trialed in "Duke University School of Medicine" in a lesser frequency.

Most popular intervention types in "Duke University School of Medicine" are "Drug" (33 trials), "Other" (6 trials), "Behavioral" (3 trials), "Device" (3 trials) and "Dietary Supplement" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Nipocalimab" (2 trials), "fluticasone" (2 trials), "Acidosis avoidance" (1 trials) and "Ad Lib Smoking" (1 trials). Other intervention names were less common.

The vast majority of trials in "Duke University School of Medicine" are 43 trials for "All" genders, 3 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Duke University School of Medicine". undefined are not yet recruiting, 11 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 26 completed trials in Duke University School of Medicine, 1 suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Duke University School of Medicine, 4 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 6 trials, and there were also 13 trials that are defined as “Not Applicable".